Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus
Open Access
- 1 December 2001
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 60 (12) , 1141-1144
- https://doi.org/10.1136/ard.60.12.1141
Abstract
OBJECTIVES To describe infectious complications and analyse their risk factors and prognostic role in adults with systemic lupus erythematosus (SLE). METHODS A monocentric cohort of 87 adults with SLE (1960–1997) was studied to determine the risk factors for infection (disease activity evaluated by SLAM and SLEDAI scores, type of organ(s) involved or any biological abnormality, specific treatments) by comparing patients who had suffered at least one infectious episode (n=35; 40%) with non-infected patients (n=52; 60%). Prognostic indicators were assessed by comparing survivors at 10 years with non-survivors. RESULTS Of the 57 infectious episodes, 47 (82%) were of bacterial origin, 16 (28%) were pneumonia, and 46 (81%) were community acquired. According to univariate analysis, significant risk factors for infection were: severe flares, lupus glomerulonephritis, oral or intravenous corticosteroids, pulse cyclophosphamide, and/or plasmapheresis. No predictors were identified at the time of SLE diagnosis. Multivariate analyses retained intravenous corticosteroids (pCONCLUSION In adults with SLE, infections are common and most often caused by community acquired bacteria. Intravenous corticosteroids and immunosuppressants are independent risk factors for infection, which is the only independent risk factor for death after 10 years of SLE evolution.Keywords
This publication has 10 references indexed in Scilit:
- UPDATE ON CYCLOPHOSPHAMIDE FOR SYSTEMIC LUPUS ERYTHEMATOSUSRheumatic Disease Clinics of North America, 2000
- Methodological issues of corticosteroid use in SLE clinical trialsLupus, 1999
- Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 PatientsMedicine, 1999
- Risk factors for serious infection during treatment with cyclophosphamide and high‐dose corticosteroids for systemic lupus erythematosusArthritis & Rheumatism, 1996
- Immunopathogenesis and spectrum of infections in systemiclupus erythematosusSeminars in Arthritis and Rheumatism, 1996
- Risk of Infectious Complications in Patients Taking GlucocorticosteroidsClinical Infectious Diseases, 1989
- Fatal Infections in Systemic Lupus ErythematosusMedicine, 1987
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- A multicenter study of outcome in systemic lupus erythematosus. ii.Arthritis & Rheumatism, 1982
- Computer analysis of factors influencing frequency of infection in systemic lupus erythematosusArthritis & Rheumatism, 1978